Estrella Immunopharma- Warrants (29/09/2028) OverviewEstrella Immunopharma- Warrants (29/09/2028) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ESLAW.
Quarterly EBIT
-$2.18M
↓ 3.76% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$13.14M
↓ 25.39% YoY
Trailing 12 months ending Mar 31, 2026